ENTITY
Sihuan Pharmaceutical Hldgs

Sihuan Pharmaceutical Hldgs (460 HK)

44
Analysis
Health CareChina
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
Refresh
12 Nov 2021 12:05

Hong Kong Buybacks: China Medical System, Sihuan, China East Edu

We highlight the top 3 companies that repurchased the most shares in HK were China Medical System (867 HK), Sihuan (460 HK), China East Education...

Logo
202 Views
Share
29 Oct 2021 10:56

Hong Kong Buybacks: China Gas, Hopson, Sihuan

We highlight in the past week the top 3 companies that repurchased the most shares from the market were China Gas (384 HK), Hopson (754 HK), Sihuan...

Logo
58 Views
Share
22 Oct 2021 10:42

Hong Kong Buybacks: Xiaomi, China Gas, Sihuan

We highlight the top 3 companies that repurchased the most shares from the market were Xiaomi (1810 HK), China Gas Holdings Limited (384 HK),...

Logo
237 Views
Share
05 Oct 2021 09:03

Sihuan Pharmaceutical (460.HK) - The Dispute with CBC Group, the Business and the Outlook

This article mainly analyzed the dispute between Sihuan and CBC Group, the potential impact of the Hugel Acquisition, Sihuan's medical beauty...

Logo
278 Views
Share
20 Jun 2021 08:59

China Healthcare Weekly (Jun.18)

The article analyzed the 2021 medical insurance catalogue adjustment plan, new document to crack down on illegal medical beauty activities, new...

Logo
188 Views
Share
x